MedPath

BIOCON LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Biological: Biocon's Human Insulin R U-500
Biological: Humulin® R U-500 (US Reference Product)
First Posted Date
2022-06-10
Last Posted Date
2023-05-09
Lead Sponsor
Biocon Limited
Target Recruit Count
78
Registration Number
NCT05413863
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH 9, Neuss, Germany

Efficacy and Safety of Itolizumab in COVID-19 Complications

Phase 2
Completed
Conditions
Acute Respiratory Distress Syndrome
Cytokine Release Syndrome
Covid19
Interventions
Drug: Best supportive care (BSC)
First Posted Date
2020-07-17
Last Posted Date
2021-06-14
Lead Sponsor
Biocon Limited
Target Recruit Count
32
Registration Number
NCT04475588
Locations
🇮🇳

Topiwala National Medical College & B. Y. L. Nair Charitable Hospital,, Mumbai, India

🇮🇳

Seth GS Medical College and KEM Hospital, Mumbai, India

🇮🇳

All India Institute Of Medical Sciences, New Delhi, India

and more 1 locations

Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil

Phase 1
Terminated
Conditions
Type 1 Diabetes Mellitus (T1DM)
Interventions
Drug: Tregopil
First Posted Date
2019-10-28
Last Posted Date
2022-06-27
Lead Sponsor
Biocon Limited
Target Recruit Count
55
Registration Number
NCT04141423
Locations
🇩🇪

Profil Mainz GmbH & Co. KG Malakoff-Passage,Rheinstraße 4C D-55116, Mainz, Germany

Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R

Phase 1
Completed
Conditions
Healthy Volunteer
Interventions
Biological: Humulin®R
Biological: Biocon Insulin R
First Posted Date
2019-07-17
Last Posted Date
2021-07-28
Lead Sponsor
Biocon Limited
Target Recruit Count
42
Registration Number
NCT04022317
Locations
🇩🇪

Profil Mainz GmbH, Mainz, Germany

Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30

Phase 1
Completed
Conditions
Healthy Volunteer
Interventions
Biological: Humulin ®70/30
Biological: Biocon Insulin 70/30
First Posted Date
2019-07-17
Last Posted Date
2020-01-30
Lead Sponsor
Biocon Limited
Target Recruit Count
78
Registration Number
NCT04022291
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH Hellersbergstr. 9 D-41460 Neuss, Neuss, Germany

🇩🇪

Profil Mainz GmbH & Co. KG Malakoff-Passage,Rheinstraße 4C D-55116, Mainz, Germany

Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N

Phase 1
Completed
Conditions
Healthy Volunteer
Interventions
Biological: Biocon Insulin N
Biological: Humulin® N
First Posted Date
2019-07-17
Last Posted Date
2020-01-30
Lead Sponsor
Biocon Limited
Target Recruit Count
90
Registration Number
NCT04022304
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients

Phase 2
Completed
Conditions
Type2 Diabetes Mellitus
Interventions
First Posted Date
2018-02-13
Last Posted Date
2020-05-15
Lead Sponsor
Biocon Limited
Target Recruit Count
143
Registration Number
NCT03430856
Locations
🇮🇳

Diacon Hospital, Bangalore, Karnataka, India

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: IN-105 (Insulin Tregopil)
Other: Placebo comparator
First Posted Date
2018-01-08
Last Posted Date
2018-01-23
Lead Sponsor
Biocon Limited
Target Recruit Count
51
Registration Number
NCT03392961

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

Phase 1
Terminated
Conditions
Type 1 Diabetes Mellitus
Interventions
First Posted Date
2009-12-21
Last Posted Date
2018-01-23
Lead Sponsor
Biocon Limited
Target Recruit Count
20
Registration Number
NCT01035801
Locations
🇮🇳

Bharti Research Institute of Diabetes and Endocrinology, Karnal, Hariyana, India

🇮🇳

Bangalore Diabetes Hospital, Bangalore, Karnataka, India

🇮🇳

Care Hospital, Hyderabad, Andhra Pradesh, India

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath